Cassava Sciences, Inc. (SAVA)
NASDAQ: SAVA · Real-Time Price · USD
3.040
+0.140 (4.83%)
Nov 25, 2025, 4:00 PM EST - Market closed
Cassava Sciences Market Cap
Cassava Sciences has a market cap or net worth of $146.86 million as of November 26, 2025. Its market cap has decreased by -88.67% in one year.
Market Cap
146.86M
Enterprise Value
40.78M
1-Year Change
-88.67%
Ranking
Category
Stock Price
$3.04
Market Cap Chart
Since July 14, 2000, Cassava Sciences's market cap has decreased from $212.59M to $146.86M, a decrease of -30.92%. That is a compound annual growth rate of -1.45%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 25, 2025 | 146.86M | 29.34% |
| Dec 31, 2024 | 113.54M | -88.04% |
| Dec 29, 2023 | 949.34M | -22.98% |
| Dec 30, 2022 | 1.23B | -29.52% |
| Dec 31, 2021 | 1.75B | 633.58% |
| Dec 31, 2020 | 238.38M | 166.23% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 951.07B |
| Johnson & Johnson | 493.13B |
| AbbVie | 411.16B |
| UnitedHealth Group | 291.83B |
| AstraZeneca | 280.49B |
| Merck & Co. | 253.19B |
| Novartis AG | 243.93B |
| Abbott Laboratories | 224.56B |